ARMC
CELG

American Research & Management Company’s Celgene Corp CELG Stock Holding History

American Research & Management Company’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,265
Closed -$1.61M – 349
2019
Q3 		$1.61M Sell
16,265
-425
-3% -$40.4K 0.49% 53
2019
Q2 		$1.54M Sell
16,690
-720
-4% -$68.4K 0.46% 55
2019
Q1 		$1.64M Hold
17,410
– – 0.47% 51
2018
Q4 		$1.12M Sell
17,410
-7,920
-31% -$585K 0.38% 60
2018
Q3 		$2.27M Buy
25,330
+315
+1% +$27.8K 0.67% 42
2018
Q2 		$1.99M Buy
25,015
+2,770
+12% +$230K 0.69% 40
2018
Q1 		$1.98M Buy
22,245
+255
+1% +$24.5K 0.65% 42
2017
Q4 		$2.29M Buy
21,990
+1,335
+6% +$151K 0.71% 41
2017
Q3 		$3.01M Buy
20,655
+325
+2% +$44.3K 0.98% 32
2017
Q2 		$2.64M Buy
20,330
+325
+2% +$39.8K 0.87% 35
2017
Q1 		$2.49M Buy
20,005
+2,065
+12% +$247K 0.89% 33
2016
Q4 		$2.08M Buy
17,940
+105
+0.6% +$11.7K 0.71% 41
2016
Q3 		$1.86M Buy
17,835
+2,980
+20% +$323K 0.68% 44
2016
Q2 		$1.47M Buy
14,855
+5,360
+56% +$554K 0.56% 50
2016
Q1 		$950K Buy
9,495
+1,550
+20% +$160K 0.4% 58
2015
Q4 		$951K Buy
7,945
+3,975
+100% +$460K 0.41% 62
2015
Q3 		$429K Buy
+3,970
New +$493K 0.19% 82
2015
Q1 		– Sell
-50
Closed -$6K – 384
2014
Q4 		$6K Hold
50
– – ﹤0.01% 314
2014
Q3 		$5K Buy
+50
New +$4.51K ﹤0.01% 328

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

American Research & Management Company's CELG Position: Q4 2019 in Review

American Research & Management Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,265 shares — an estimated $1.61M sold.

American Research & Management Company first reported a position in CELG in Q3 2014 and held it in 19 quarters. The position peaked at $3.01M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • American Research & Management Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • American Research & Management Company sold 16,265 Celgene Corp shares in Q4 2019, an estimated $1.61M.
  • American Research & Management Company first reported a position in Celgene Corp in Q3 2014 and held it in 19 quarters.
  • American Research & Management Company's Celgene Corp position peaked at $3.01M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on American Research & Management Company's 13F filing for Q4 2019, filed 17 Jan 2020.